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Background: Patients (pts) with chronic heart failure (CHF) at risk of sudden cardiac death (SCD) are often treated with implantable cardiac 
defibrillator (ICD), but current criteria for device use, based largely on LVEF, leads many pts receiving ICDs that never deliver therapy. It is of clinical 
significance to identify CHF pts with reduced LVEF who do not require ICD. Although cardiac MIBG imaging provides prognostic information in CHF 
pts, it remains unclear whether the MIBG imaging could identify CHF pts at low risk for SCD without the requirement of ICD.
methods: We studied 81 CHF pts with LVEF<35%(26±6%), who were completely followed up for 5 years after cardiac MIBG imaging. We divided the 
heart to mediastinum ratio (H/M) at the delayed image and washout rate (WR) into 6 grades, scored as 0 to 5, according to the deviation degree of 
normal control values (H/M:2.65±0.32, WR:9.6±8.5%), respectively, and these pts were classified into 3 groups according to the MIBG score defined 
as the sum of WR and H/M scores; low (1-4), intermediate (5-8) and high (9-11) score groups.
results: During the follow-up period, 11 pts had SCD. At Cox analysis, only MIBG score was significantly associated with SCD. Pts with low MIBG 
score had significantly lower risk of SCD (low (n=19); 0%, intermediate (n=37); 11%, high (n=25); 28%, p=0.028). Positive predictive value of low 
MIBG score for the identification of pts without SCD was 100%.
conclusions: The cardiac MIBG score could identify CHF pts with LVEF<35% at low risk of SCD for 5 years.
 
